VEGFA and nasopharyngeal carcinoma: Exosome-derived miR-17-5p can promote angiogenesis in nasopharyngeal carcinoma by targeting BAMBI, and can promote proliferation and migration of nasopharyngeal carcinoma cells by regulating the AKT/VEGF-A signaling pathway (43).